Tallman MS - Search Results

1

Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia.

Epstein-Peterson ZD, Derkach A, Geyer S, Mrózek K, Kohlschmidt J, Park JH, Rajeeve S, Stein EM, Zhang Y, Iland H, Campbell LJ, Larson RA, Poiré X, Powell BL, Stock W, Stone RM, Tallman MS. Epstein-Peterson ZD, et al. Among authors: tallman ms. Blood Adv. 2022 Jun 14;6(11):3433-3439. doi: 10.1182/bloodadvances.2021006682. Blood Adv. 2022. PMID: 35349669 Free PMC article.

2

Reassessing the hemostatic disorder associated with acute promyelocytic leukemia.

Tallman MS, Kwaan HC. Tallman MS, et al. Blood. 1992 Feb 1;79(3):543-53. Blood. 1992. PMID: 1732003 Free article. Review. No abstract available.

3

Detection of differentiation in acute promyelocytic leukemia.

Tallman MS, Kwaan HC, Weitzman SA. Tallman MS, et al. Blood. 1991 Oct 1;78(7):1892-3. Blood. 1991. PMID: 1912572 Free article. No abstract available.

4

Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid.

Gallagher RE, Li YP, Rao S, Paietta E, Andersen J, Etkind P, Bennett JM, Tallman MS, Wiernik PH. Gallagher RE, et al. Among authors: tallman ms. Blood. 1995 Aug 15;86(4):1540-7. Blood. 1995. PMID: 7632962 Free article.

5

All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.

Tallman MS. Tallman MS. Semin Hematol. 1994 Oct;31(4 Suppl 5):38-48. Semin Hematol. 1994. PMID: 7831584 Review.

6

Acute promyelocytic leukemia: a paradigm for differentiation therapy with retinoic acid.

Tallman MS, Rowe JM. Tallman MS, et al. Blood Rev. 1994 Jun;8(2):70-8. doi: 10.1016/s0268-960x(05)80010-4. Blood Rev. 1994. PMID: 7950477 Review. No abstract available.

7

Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine.

Wheaton S, Tallman MS, Hakimian D, Peterson L. Wheaton S, et al. Among authors: tallman ms. Blood. 1996 Feb 15;87(4):1556-60. Blood. 1996. PMID: 8608247 Free article.

8

Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience.

Tallman MS, Hakimian D, Rademaker AW, Zanzig C, Wollins E, Rose E, Peterson LC. Tallman MS, et al. Blood. 1996 Sep 15;88(6):1954-9. Blood. 1996. PMID: 8822913 Free article. Clinical Trial.

9

RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study.

Li YP, Andersen J, Zelent A, Rao S, Paietta E, Tallman MS, Wiernik PH, Gallagher RE. Li YP, et al. Among authors: tallman ms. Blood. 1997 Jul 1;90(1):306-12. Blood. 1997. PMID: 9207466 Free article.

10

Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.

Gallagher RE, Willman CL, Slack JL, Andersen JW, Li YP, Viswanatha D, Bloomfield CD, Appelbaum FR, Schiffer CA, Tallman MS, Wiernik PH. Gallagher RE, et al. Among authors: tallman ms. Blood. 1997 Aug 15;90(4):1656-63. Blood. 1997. PMID: 9269786 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

668 results

Search Page